What is Morgan Stanley's price target for FOLD?

Morgan Stanley's latest stated price target for Amicus Therapeutics Inc. (FOLD) is $108, from its action on Jul 17, 2025.

What is Morgan Stanley's rating on FOLD?

Morgan Stanley rates FOLD Overweight, a bullish rating, as of Jul 17, 2025.

When did Morgan Stanley last change its view on FOLD?

On Jul 17, 2025, Morgan Stanley upgrades to Overweight from Equal-Weight, price target $108.

Analyst firms · Morgan Stanley · FOLD

Morgan Stanley FOLD price target and rating history

Amicus Therapeutics Inc. (FOLD) · Health Care

Morgan Stanley rates Amicus Therapeutics Inc. (FOLD) Overweight with a $108 price target, as of its latest action on Jul 17, 2025. It has published 4 rating actions on FOLD since September 2022, including 2 upgrades and 1 downgrade. Across 4 firms with a FOLD price target in the last 12 months, the median target is $14.50.

Current rating: Overweight
Price target: $108
Median target, all firms: $14.50
Actions on FOLD: 4

Morgan Stanley price target on FOLD

Morgan Stanley price target on FOLD, each point a stated target, September 2022 to July 2025.

Every Morgan Stanley rating on FOLD

Jul 17, 2025
UpgradeMorgan Stanley upgrades to Overweight from Equal-Weight, price target $108
Dec 13, 2024
DowngradeMorgan Stanley downgrades to Equal-Weight from Overweight, price target $17 to $12
Dec 19, 2023
UpgradeMorgan Stanley upgrades to Overweight from Equal-Weight, price target $15 to $20
Sep 9, 2022
InitiateMorgan Stanley starts coverage at Equal-Weight, price target $14

How other firms rate FOLD

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
Jefferies	Hold	$14.50	Jan 22, 2026
Leerink Partners	Market Perform	$14.50	Dec 29, 2025
TD Cowen	Hold	$14.50	Dec 22, 2025
Citigroup	Buy	$17	Dec 17, 2025

Questions about Morgan Stanley and FOLD

What is Morgan Stanley's price target for FOLD?: Morgan Stanley's latest stated price target for Amicus Therapeutics Inc. (FOLD) is $108, from its action on Jul 17, 2025.
What is Morgan Stanley's rating on FOLD?: Morgan Stanley rates FOLD Overweight, a bullish rating, as of Jul 17, 2025.
When did Morgan Stanley last change its view on FOLD?: On Jul 17, 2025, Morgan Stanley upgrades to Overweight from Equal-Weight, price target $108.
How does Morgan Stanley's FOLD target compare with other analysts?: Across 4 firms with a FOLD price target in the last 12 months, the median target is $14.50.

More FOLD rating histories

Leerink Partners4

All Morgan Stanley ratings FOLD news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.